TY - JOUR
T1 - Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
AU - Bhopalwala, Huzefa
AU - Dewaswala, Nakeya
AU - Liu, Sijia
AU - Scott, Christopher G.
AU - Welper, James M.
AU - Akinnusotu, Oluwatoyin
AU - Bos, Johan Martijn
AU - Ommen, Steve R.
AU - Ackerman, Michael J.
AU - Pellikka, Patricia A.
AU - Geske, Jeffrey B.
AU - Noseworthy, Peter
AU - Arruda-Olson, Adelaide M.
N1 - Funding Information:
The research reported in this publication was supported by the National Heart, Lung, and Blood Institute of National Institutes of Health (K01HL124045), Mayo Clinic K2R, and the Tsai Family Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank Katie M. Nagel for secretarial support.
Funding Information:
The research reported in this publication was supported by the National Heart, Lung, and Blood Institute of National Institutes of Health (K01HL124045), Mayo Clinic K2R, and the Tsai Family Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020 The Authors. Echocardiography published by Wiley Periodicals LLC
PY - 2021/2
Y1 - 2021/2
N2 - Background: A subset of patients with hypertrophic cardiomyopathy (HCM) is at high risk of sudden cardiac death (SCD). Practice guidelines endorse use of a risk calculator, which requires entry of left atrial (LA) diameter. However, American Society of Echocardiography (ASE) guidelines recommend the use of LA volume index (LAVI) for routine quantification of LA size. The aims of this study were to (a) develop a model to estimate LA diameter from LAVI and (b) evaluate whether substitution of measured LA diameter by estimated LA diameter derived from LAVI reclassifies HCM-SCD risk. Methods: The study cohort was comprised of 500 randomly selected HCM patients who underwent transthoracic echocardiography (TTE). LA diameter and LAVI were measured offline using digital clips from TTE. Linear regression models were developed to estimate LA diameter from LAVI. A European Society of Cardiology endorsed equation estimated SCD risk, which was measured using LA diameter and estimated LA diameter derived from LAVI. Results: The mean LAVI was 48.5 ± 18.8 mL/m2. The derived LA diameter was 45.1 mm (SD: 5.5 mm), similar to the measured LA diameter (45.1 mm, SD: 7.1 mm). Median SCD risk at 5 years estimated by measured LA diameter was 2.22% (interquartile range (IQR): 1.39, 3.56), while median risk calculated by estimated LA diameter was 2.18% (IQR: 1.44, 3.52). 476/500 (95%) patients maintained the same risk classification regardless of whether the measured or estimated LA diameter was used. Conclusions: Substitution of measured LA diameter by estimated LA diameter in the HCM-SCD calculator did not reclassify risk.
AB - Background: A subset of patients with hypertrophic cardiomyopathy (HCM) is at high risk of sudden cardiac death (SCD). Practice guidelines endorse use of a risk calculator, which requires entry of left atrial (LA) diameter. However, American Society of Echocardiography (ASE) guidelines recommend the use of LA volume index (LAVI) for routine quantification of LA size. The aims of this study were to (a) develop a model to estimate LA diameter from LAVI and (b) evaluate whether substitution of measured LA diameter by estimated LA diameter derived from LAVI reclassifies HCM-SCD risk. Methods: The study cohort was comprised of 500 randomly selected HCM patients who underwent transthoracic echocardiography (TTE). LA diameter and LAVI were measured offline using digital clips from TTE. Linear regression models were developed to estimate LA diameter from LAVI. A European Society of Cardiology endorsed equation estimated SCD risk, which was measured using LA diameter and estimated LA diameter derived from LAVI. Results: The mean LAVI was 48.5 ± 18.8 mL/m2. The derived LA diameter was 45.1 mm (SD: 5.5 mm), similar to the measured LA diameter (45.1 mm, SD: 7.1 mm). Median SCD risk at 5 years estimated by measured LA diameter was 2.22% (interquartile range (IQR): 1.39, 3.56), while median risk calculated by estimated LA diameter was 2.18% (IQR: 1.44, 3.52). 476/500 (95%) patients maintained the same risk classification regardless of whether the measured or estimated LA diameter was used. Conclusions: Substitution of measured LA diameter by estimated LA diameter in the HCM-SCD calculator did not reclassify risk.
KW - hypertrophic cardiomyopathy
KW - left atrial diameter
KW - left atrial volume index
KW - sudden cardiac death risk
UR - http://www.scopus.com/inward/record.url?scp=85097628738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097628738&partnerID=8YFLogxK
U2 - 10.1111/echo.14943
DO - 10.1111/echo.14943
M3 - Article
C2 - 33325582
AN - SCOPUS:85097628738
SN - 0742-2822
VL - 38
SP - 183
EP - 188
JO - Echocardiography
JF - Echocardiography
IS - 2
ER -